{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:54:36Z","timestamp":1788346476620,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.transci.2018.02.014","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T08:07:07Z","timestamp":1519114027000},"page":"35-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The use of emergency apheresis in the management of plasma cell disorders"],"prefix":"10.1016","volume":"57","author":[{"given":"Sevgi","family":"Kalayoglu-Besisik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"978","key":"10.1016\/j.transci.2018.02.014_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/pgmj.2006.054627","article-title":"Management of paraproteinaemia","volume":"83","author":"Cook","year":"2007","journal-title":"Postgrad Med J"},{"issue":"7-8","key":"10.1016\/j.transci.2018.02.014_bib0010","first-page":"S4","article-title":"Hemorheology: pathophysiological significance","volume":"6","author":"Stolzt","year":"1985","journal-title":"Acta Med Port"},{"issue":"1","key":"10.1016\/j.transci.2018.02.014_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1537-2995.1982.22182154217.x","article-title":"Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests","volume":"22","author":"Beck","year":"1982","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.transci.2018.02.014_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(85)90540-6","article-title":"Evaluation of hyperviscosity in monoclonal gammopathies","volume":"79","author":"Crawford","year":"1985","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.transci.2018.02.014_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-2003-44554","article-title":"Hyperviscosity Syndrome in Plasma Cell Dyscrasias","volume":"29","author":"Mehta","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.transci.2018.02.014_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3816\/CLM.2009.n.026","article-title":"Waldenstr\u00f6m\u2019s Macroglobulinemia: hyperviscosity syndrome and Cryoglobulinemia","volume":"9","author":"Stone","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"issue":"2","key":"10.1016\/j.transci.2018.02.014_bib0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.clml.2013.02.013","article-title":"Role of plasmapheresis in Waldenstr\u00f6m\u2019s Macroglobulinemia","volume":"13","author":"Stone","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"10.1016\/j.transci.2018.02.014_bib0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1744-9987.12187","article-title":"Double-filtration plasmapheresis for treatment of acute renal failure in a multiple Myeloma Patient","volume":"18","author":"Jiang","year":"2014","journal-title":"Ther Apher Dial"},{"issue":"1","key":"10.1016\/j.transci.2018.02.014_bib0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.beha.2005.01.004","article-title":"Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma Exchange","volume":"19","author":"MacLeod","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.transci.2018.02.014_bib0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/asheducation.V2012.1.7.3797920","article-title":"Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines","volume":"2012","author":"Winter","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.transci.2018.02.014_bib0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2141.1981.00627.x","article-title":"Coagulation abnormalities following intensive plasma exchange on the cell separator. II. Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III","volume":"48","author":"Chirnside","year":"1981","journal-title":"Br J Haematol ."},{"issue":"2","key":"10.1016\/j.transci.2018.02.014_bib0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jca.2920030209","article-title":"The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasmaimmunoglobulin, and complement levels","volume":"3","author":"Wood","year":"1986","journal-title":"J Clin Apher"},{"issue":"11","key":"10.1016\/j.transci.2018.02.014_bib0065","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archopht.124.11.1601","article-title":"Hyperviscosity-related retinopathy in Waldenstrom macroglobulinemia","volume":"124","author":"Menke","year":"2006","journal-title":"Arch Ophtalmol"},{"issue":"3","key":"10.1016\/j.transci.2018.02.014_bib0070","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1167\/iovs.07-1254","article-title":"Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia","volume":"49","author":"Menke","year":"2008","journal-title":"Invest Ophtalmol Vis Sci"},{"key":"10.1016\/j.transci.2018.02.014_bib0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-3-25","article-title":"Mixed cryoglobulinemia","volume":"3","author":"Ferri","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.transci.2018.02.014_bib0080","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood.V55.5.866.bloodjournal555866","article-title":"Plasmapheresis with return of cryoglobulin-depleted autologous plasma (cryoglobulinpheresis) in cryoglobulinemia","volume":"55","author":"McLeod","year":"1980","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.transci.2018.02.014_bib0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/JIR.S114067","article-title":"Managing refractory cryoglobulinemic vasculitis: challenges and solutions","volume":"8","author":"Ostojic","year":"2017","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.transci.2018.02.014_bib0090","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2015-01-553974","article-title":"How I treat Waldenstr\u00f6m macroglobulinemia","volume":"126","author":"Treon","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transci.2018.02.014_bib0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12883-016-0532-4","article-title":"Paraproteinemic neuropathy: a practical review","volume":"16","author":"Rison","year":"2016","journal-title":"BMC Neurol"},{"issue":"6","key":"10.1016\/j.transci.2018.02.014_bib0100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40620-016-0347-9","article-title":"Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology","volume":"29","author":"Fabbrini","year":"2016","journal-title":"J Nephrol"},{"issue":"3","key":"10.1016\/j.transci.2018.02.014_bib0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1526-0968.2001.00301.x","article-title":"Therapeutic apheresis for the renal complications of multiple Myeloma and the Dysglobulinemias","volume":"5","author":"Kaplan","year":"2001","journal-title":"Ther Apher"},{"issue":"1","key":"10.1016\/j.transci.2018.02.014_bib0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1526-0968.1999.00138.x","article-title":"Therapeutic apheresis for renal disorders","volume":"3","author":"Kaplan","year":"1999","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2018.02.014_bib0115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.ackd.2012.06.003","article-title":"The rationale and evidence base for the direct removal of serum-free light chains in the management of Myeloma kidney","volume":"19","author":"Cockwell","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1016\/j.transci.2018.02.014_bib0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1542-4758.2010.00481.x","article-title":"Role of plasmapheresis in the management of myeloma kidney: a systematic review","volume":"14","author":"Gupta","year":"2010","journal-title":"Hemodial Int"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305021830048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305021830048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T10:02:46Z","timestamp":1719828166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305021830048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S147305021830048X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2018.02.014","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of emergency apheresis in the management of plasma cell disorders","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2018.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}